Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2015 May 20;35(4):603–609. doi: 10.1007/s10792-015-0081-7

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2015

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

PMC Copyright notice

Fig. 4 — Successive ocular coherence tomography (OCT) of horizontal sections (7.0 mm) from the right and left eyes shows the evolution of subretinal and intraretinal fluid. Central foveal thickness (μm) is indicated for each OCT exam. Images correspond to the OCT scans taken 4 weeks after the last (third) injection of each treatment cycle. Baseline image was taken after a 1-month washout period after the prestudy treatment (near-monthly ranibizumab injections). Clear improvement is observed during the two aflibercept treatment cycles, whereas worsening is observed during the two ranibizumab treatment cycles. CFT Central Foveal Thickness